Nandita Bose

4PUBLICATIONS
29CO-AUTHORS
Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 04, 2025
In Vivo Tumor Growth Control by General Control Nonderepressible 2-Targeting Agents Results from Kinase Activation.

Feven Tameire, Paulina Wojnarowicz, Crissy Dudgeon

|Aug 20, 2025
In Vivo Tumor Growth Control by General Control Nonderepressible 2-Targeting Agents Results from Kinase Activation.

Feven Tameire, Paulina Wojnarowicz, Crissy Dudgeon

|Sep 21, 2023
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors.

Michael E Stokes, Veronica Calvo, Sho Fujisawa

|Apr 17, 2019
Immune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy Volunteers.

Nandita Bose, Nadine R Ottoson, Xiaohong Qiu

Pageof 1